NVS-PAK1-1 [1783816-74-9]

Commande minimum 2

Référence T16367-1mg

Conditionnement : 1mg

Marque : TargetMol

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

NVS-PAK1-1

Copy Product Info
NVS-PAK1-1 is an effective and selective allosteric PAK1 inhibitor (IC50: 5 nM).
NVS-PAK1-1
Cas No. 1783816-74-9
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.35%
Appearance:Solid
Color:White
COA HNMR LCMS

Product Introduction

Bioactivity
Description
NVS-PAK1-1 is an effective and selective allosteric PAK1 inhibitor (IC50: 5 nM).
Targets & IC50
PAK1:5 nM
In vitro
NVS-PAK1-1 inhibits the proliferation of the Su86.86 cell line only above a concentration of 2 μM, consistent with the observation. NVS-PAK1-1 (6-20 μM) inhibits the phosphorylation of the downstream substrate MEK1 Ser289. Inhibition of downstream signaling, by applying a mixture of NVS-PAK1-1 and PAK2 shRNA, and cell proliferation at a significantly lower 0.21 μM concentration is achieved. NVS-PAK1-1 shows high selectivity for inhibition of PAK1 over other PAK isoforms and the kinome in general. NVS-PAK1-1 has a biochemical PAK1 Kd of 7 nM and a PAK2 Kd of 400 nM. NVS-PAK1-1 displays excellent activity in biochemical assays and an exceptional selectivity profile against other known kinases .
In vivo
NVS-PAK1-1 displays relatively poor stability in rat liver microsomes (RLM). This would limit its application for in vivo studies (t1/2 in RLM 3.5 min).
Chemical Properties
Molecular Weight479.93
FormulaC23H25ClF3N5O
Cas No.1783816-74-9
SmilesCC(C)NC(=O)N1CC[C@@H](C1)NC1=Nc2cc(F)ccc2N(CC(F)F)c2ccc(Cl)cc12
Relative Density.1.42 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 145 mg/mL (302.13 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Saline: < 10 mg/mL (20.84 mM), Lower concentrations may be soluble, but exact solubility limit is unknown.
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10 mg/mL (20.84 mM), Solution.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0836 mL10.4182 mL20.8364 mL104.1819 mL
5 mM0.4167 mL2.0836 mL4.1673 mL20.8364 mL
10 mM0.2084 mL1.0418 mL2.0836 mL10.4182 mL
20 mM0.1042 mL0.5209 mL1.0418 mL5.2091 mL
50 mM0.0417 mL0.2084 mL0.4167 mL2.0836 mL
100 mM0.0208 mL0.1042 mL0.2084 mL1.0418 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Vous serez peut-être également intéressé par les produits suivants :



Référence
Description
Cond.
Prix HT
T1076-50mg
 50mg 
T2123-2mg
 2mg 
T2644-2mg
 2mg